Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations
Valentina Colapicchioni et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2022)
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy
Xiaoxuan Xu et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
Wencheng Wu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Nanotechnological approaches for pentamidine delivery
Ilaria Andreana et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing ofDUX4
Maria Sofia Falzarano et al.
NUCLEIC ACID THERAPEUTICS (2021)
Clinical translation of nanomedicines: Challenges, opportunities, and keys
Mahmoud A. Younis et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Roberta Sartori et al.
NATURE COMMUNICATIONS (2021)
Duchenne muscular dystrophy
Dongsheng Duan et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
Ilaria Andreana et al.
PHARMACEUTICS (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Antisense technology: an overview and prospectus
Stanley T. Crooke et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Murine models of Duchenne muscular dystrophy: is there a best model?
Kristy Swiderski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)
Sex as an important factor in nanomedicine
Mohammah Javad Hajipour et al.
NATURE COMMUNICATIONS (2021)
Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems
Barbara Stella et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Diversity of extracellular matrix morphology in vertebrate skeletal muscle
David A. Sleboda et al.
JOURNAL OF MORPHOLOGY (2020)
Update on Muscular Dystrophies with Focus on Novel Treatments and Biomarkers
Neil Datta et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
Giuseppe Ronzitti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling
Juulia H. Lautaoja et al.
BIOMOLECULES (2020)
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan et al.
ACS NANO (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life
Farnaz Sadat Mirzazadeh Tekie et al.
SCIENTIFIC REPORTS (2020)
Harnessing Inorganic Nanoparticles to Direct Macrophage Polarization for Skeletal Muscle Regeneration
Francesca Corsi et al.
NANOMATERIALS (2020)
Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy
Keren Turjeman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Enhanced Delivery of Plasmid DNA to Skeletal Muscle Cells using a DLC8-Binding Peptide and ASSLNIA-Modified PAMAM Dendrimer
Samuel D. Jativa et al.
MOLECULAR PHARMACEUTICS (2019)
The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells
M. Leontien van der Bent et al.
FASEB JOURNAL (2019)
Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
Junling Zhao et al.
MOLECULAR MEDICINE (2019)
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Guojun Chen et al.
NATURE NANOTECHNOLOGY (2019)
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Alireza Shahryari et al.
FRONTIERS IN GENETICS (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications
Guangbao Yang et al.
ADVANCED MATERIALS (2019)
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Lucia Salvioni et al.
CANCERS (2019)
Stabilization of Angiotensin-(1-7) in Cardioprotective Solutions
Miriam Russ et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2019)
Role of proteoglycans and glycosaminoglycans in Duchenne muscular dystrophy
Laurino Carmen et al.
GLYCOBIOLOGY (2019)
Iron oxide nanoparticles as multimodal imaging tools
Edouard Alphandery
RSC ADVANCES (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues
Xin Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
Eric M. Mastria et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Regulation of fibrosis in muscular dystrophy
Lucas R. Smith et al.
MATRIX BIOLOGY (2018)
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Dongsheng Duan
MOLECULAR THERAPY (2018)
Advances in targeting the folate receptor in the treatment/imaging of cancers
Marcos Fernandez et al.
CHEMICAL SCIENCE (2018)
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
D. C. Luther et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Synthesis and Antisense Properties of 2′ β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent
Xiao-Yang He et al.
MOLECULES (2018)
Nanomedicine: Principles, Properties, and Regulatory Issues
Sara Soares et al.
FRONTIERS IN CHEMISTRY (2018)
Functional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice
Theresa M. Raimondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cancer nanomedicines: oversold or underappreciated?
Roy van der Meel et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts
Ji Young Yhee et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies
Geoffrey A. Pietersz et al.
NANOMEDICINE (2017)
Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system
Ayse Basak Engin et al.
PARTICLE AND FIBRE TOXICOLOGY (2017)
Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis
Peter S. Zammit
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Myotonic Dystrophies: Stateofthe Art of New Therapeutic Developments for the CNS
Genevieve Gourdon et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Novel biomaterial strategies for controlled growth factor delivery for biomedical applications
Zhenming Wang et al.
NPG ASIA MATERIALS (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Mechanisms and Barriers in Cancer Nanomedicine: Adressing Challenges, Looking for Solutions
Thomas J. Anchordoquy et al.
ACS NANO (2017)
Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
Priya Satalkar et al.
SCIENCE AND ENGINEERING ETHICS (2016)
Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation Therapy
Jeffrey S. Willey et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2016)
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
Rui Xue Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
CRISPR-Cas adaptation: insights into the mechanism of action
Gil Amitai et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity
Xue-Hai Liang et al.
NUCLEIC ACIDS RESEARCH (2016)
Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists
Ana C. Silva et al.
CURRENT DRUG METABOLISM (2015)
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Joe W. McGreevy et al.
DISEASE MODELS & MECHANISMS (2015)
Molecular Docking and Structure-Based Drug Design Strategies
Leonardo G. Ferreira et al.
MOLECULES (2015)
QUANTITATIVE AND QUALITATIVE ADAPTATIONS OF MUSCLE FIBERS TO GLUCOCORTICOIDS
Marco Alessandro Minetto et al.
MUSCLE & NERVE (2015)
Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific
K. -H. Chen et al.
NANOSCALE (2015)
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver et al.
NATURE (2015)
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
Aurelie Goyenvalle et al.
NATURE MEDICINE (2015)
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function
Kristin P. Bibee et al.
FASEB JOURNAL (2014)
Role of toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle
Andrea Henriques-Pons et al.
HUMAN MOLECULAR GENETICS (2014)
RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo
Yinghuan Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
Fangfang Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Effective Dystrophin Restoration by a Novel Muscle-Homing Peptide-Morpholino Conjugate in Dystrophin-Deficient mdx Mice
Xianjun Gao et al.
MOLECULAR THERAPY (2014)
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang et al.
NATURE REVIEWS CARDIOLOGY (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
Larissa Y. Rizzo et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
Efficacy of Muscle Exercise in Patients with Muscular Dystrophy: A Systematic Review Showing a Missed Opportunity to Improve Outcomes
Silvia Gianola et al.
PLOS ONE (2013)
Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-Linked Low-Molecular-Weight Polyethylenimine as Gene Delivery Carriers in Cell Culture and Dystrophic mdx Mice
Mingxing Wang et al.
BIOCONJUGATE CHEMISTRY (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
C. Li et al.
GENE THERAPY (2012)
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Jieqiong Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Effective Drug Delivery System for Duchenne Muscular Dystrophy Using Hybrid Liposomes Including Gentamicin along with Reduced Toxicity
Mamiko Yukihara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Diffusion of Particles in the Extracellular Matrix: The Effect of Repulsive Electrostatic Interactions
Triantafyllos Stylianopoulos et al.
BIOPHYSICAL JOURNAL (2010)
Muscular Dystrophies: Histology, Immunohistochemistry, Molecular Genetics and Management
Costanza Lamperti et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Polyplex nanomicelle promotes hydrodynamic gene introduction to skeletal muscle
Keiji Itaka et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Selective Filtering of Particles by the Extracellular Matrix: An Electrostatic Bandpass
Oliver Lieleg et al.
BIOPHYSICAL JOURNAL (2009)
Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides
Shashank R Sirsi et al.
JOURNAL OF NANOBIOTECHNOLOGY (2009)
TNF-α and glucocorticoid receptor interaction in L6 muscle cells:: A cooperative downregulation of myosin heavy chain
Bassem H. Dekelbab et al.
STEROIDS (2007)
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
Ludovic Arnold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle
P Dunant et al.
MUSCLE & NERVE (2003)
Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier
J Wang et al.
GENE THERAPY (2002)
Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors
A Pluen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
